FDA.reportPublic FDA data

{12 (risedronate sodium 35 MG Oral Tablet [Actonel]) } Pack [Actonel 35 12-Week]

RxCUI
905101
RxNorm name
{12 (risedronate sodium 35 MG Oral Tablet [Actonel]) } Pack [Actonel 35 12-Week]
Display name
{12 (risedronate sodium 35 MG Oral Tablet [Actonel]) } Pack [Actonel 35 12-Week]
Full name
{12 (risedronate sodium 35 MG Oral Tablet [Actonel]) } Pack [Actonel 35 12-Week]
Term type
BPCK
Status
DailyMed mapping
Updated
2026-06-04 23:38:50

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ActonelRISEDRONATE SODIUMAllergan, Inc.24ed00e0-25e2-49a8-97fc-66c1b417dc0b2026-02-04Warnings, Adverse reactionsExact identifier
rxcui: 905101

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
24ed00e0-25e2-49a8-97fc-66c1b417dc0b{12 (risedronate sodium 35 MG Oral Tablet [Actonel]) } Pack [Actonel 35 12-Week] [BPCK] · Actonel 35 12-Week Once Weekly Dosepack [PSN] · Actonel 35 12-Week Once Weekly Dosepack [SY]331These highlights do not include all the information needed to use ACTONEL safely and effectively. See full prescribing information for ACTONEL. ACTONEL ® ( risedronate sodium ) tablets , for oral use Initial U.S. Approval: 199 820260204